<DOC>
	<DOC>NCT02581449</DOC>
	<brief_summary>The purpose of the study is to evaluate the effect of omega-3 fatty acids supplementation on pediatric patients undergoing hemodialysis via the measurement of the following before and after omega-3 administration:oxidative stress markers, inflammatory markers and serum lipids.</brief_summary>
	<brief_title>Effect of Omega-3 Fatty Acids on Oxidative Stress and Dyslipidemia in Pediatric Patients Undergoing Hemodialysis</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>Patients between 8 and 18 years old Patients treated with HD for at least 6 months Patients with malignancy and active inflammatory disease. Patients who received vitamin E or any antioxidant treatment during the past 3 months.</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>omega-3 fatty acids</keyword>
	<keyword>hemodialysis</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>dyslipidemia</keyword>
</DOC>